Study indicates surge in GLP-1RA prescriptions to treat obesity and prevent its complicationsStudy indicates surge in GLP-1RA prescriptions to treat obesity and prevent its complications
Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States. Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like Read More
Sister hormone of GLP-1 could lead to better weight-loss drugsSister hormone of GLP-1 could lead to better weight-loss drugs
Much like the Cold War space race, the world’s pharmaceutical giants are currently scrambling to produce the best weight-loss drug. They all want to be the first to explore the nooks and crannies of the body in order to be able to design the optimal drug. However, several pharmaceutical giants disagree on what the next Read More
Diabetes drugs like Ozempic lower cancer risks: StudyDiabetes drugs like Ozempic lower cancer risks: Study
A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday. A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Semaglutide leads to greater weight loss in women than men with HF and improves HF symptomsSemaglutide leads to greater weight loss in women than men with HF and improves HF symptoms
Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options. Women experienced greater weight loss and the same symptom benefits compared with men. Semaglutide, a medication initially developed for type 2 diabetes and obesity, Read More
Stop criticising Ozempic – it could be a solution to more than obesityStop criticising Ozempic – it could be a solution to more than obesity
Weight-loss drugs are proving their worth against addiction, high blood pressure and even depression, so let’s stop criticising them as a quick fix and start exploring their true potential Weight-loss drugs are proving their worth against addiction, high blood pressure and even depression, so let’s stop criticising them as a quick fix and start exploring Read More